Aripiprazole

About Alembic Pharmaceuticals

Alembic Pharmaceuticals' mission is to accelerate access to quality, affordable medicines globally through a vertically integrated model spanning API synthesis to finished dosage forms. The company has achieved significant scale, with over $250M in annual US frontend sales, a pipeline of 252 ANDA filings, and a strategic foray into proprietary drug discovery with three disclosed NCE candidates. Its strategy balances cash-generating generics businesses with disciplined R&D investments in complex generics and novel therapeutics to drive long-term, high-margin growth.

Therapeutic Areas